Intuitive Surgical Inc. (ISRG) Stock

NASDAQ
HealthcareMedical Devices Website

ISRG has an Alpha Score of 37 out of 100 (weak), computed on Nov 13, 2026 from 3 of 4 sub-scores. 18 members of Congress disclosed 65 trades in ISRG since 2016: 33 purchases and 32 sales, most recently Alan Armstrong (purchase, Mar 27, 2026). 4 of the hedge funds AlphaScala tracks reported ISRG in 13F filings for the quarter ended Sep 30, 2026; the largest reported position is Citadel's at $557.25M. Company insiders reported 0 open-market buys and 24 sales on SEC Form 4 in the 90 days to Nov 20, 2026. Its trailing P/E ratio is 54.9 and its net margin 25.5% (key statistics as of Nov 7, 2026).

$399.05
-2.01%
Last price
Source: Finnhub
Alpha Score
37
Weak

What is ISRG's Alpha Score?

How it works →

Alpha Score of 37 reflects weak overall profile with weak momentum, poor value, strong quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.

Momentum
42
Weak
Value
6
Poor
Quality
74
Moderate

Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.

Computed Nov 13, 2026

A rules-based research rating, not a recommendation to buy or sell.

Which members of Congress traded Intuitive Surgical Inc. (ISRG)?

Members
18
Disclosed trades
65
Purchases
33
Sales
32

Most recent: Alan Armstrong (purchase, Mar 27, 2026); records start Nov 23, 2016.

PoliticianTrade dateTypeAmount
Alan Armstrong
R-OK · Senate
2026-03-27purchase$1k – $15k
Gil Cisneros
D-CA · House
2026-01-30purchase$1k – $15k
Markwayne Mullin
R-OK · Senate
2025-12-29purchase$15k – $50k
Gil Cisneros
D-CA · House
2025-12-10purchase$1k – $15k
Gil Cisneros
D-CA · House
2025-11-18purchase$1k – $15k
Markwayne Mullin
R-OK · Senate
2025-09-24purchase$50k – $100k
Josh Gottheimer
D-NJ · House
2025-09-03partial sale$1k – $15k
Lisa McClain
R-MI · House
2025-07-16sale$1k – $15k

From STOCK Act periodic transaction reports. House filings as of Nov 19, 2026.

Every member of Congress who traded ISRG, with filing lags →

Which hedge funds own ISRG?

From 13F filings
FundShares HeldPosition ValueChange vs prior Q
Citadel
Ken Griffin
1.37M$557.25M+192%
Coatue Management
Philippe Laffont
628K$255.20M-21%
Marshall Wace587K$238.67M+433%
Renaissance Technologies
Jim Simons (founder)
456K$185.59M-10%

13F holdings as of Sep 30, 2026

Explore all tracked funds →

Are Intuitive Surgical Inc. insiders buying or selling?

SEC Form 4 filings
90 days to Nov 20, 2026
Buys
0
Sells
24
Net $
-$20.2M
Unique insiders
6
DateInsiderRoleTypeSharesValue
Nov 20, 26Brosius MarkEVP & Chief Mfg and Supply ChaSELL46$19K
Nov 19, 26Brosius MarkEVP & Chief Mfg and Supply ChaSELL46$19K
Nov 18, 26Brosius MarkEVP & Chief Mfg and Supply ChaSELL46$20K
Nov 17, 26Brosius MarkEVP & Chief Mfg and Supply ChaSELL46$20K
Nov 16, 26Brosius MarkEVP & Chief Mfg and Supply ChaSELL46$20K
Nov 10, 26Loeb GaryEVP & Chief Legal and ComplianSELL400$183K
Nov 4, 26Barratt Craig HDirectorSELL1.1K$529K
Nov 4, 26Guthart Gary SDirectorSELL10.0K$4.6M
Oct 30, 26Widman FredrikVP Corporate ControllerSELL5.4K$2.4M
Oct 30, 26Brosius MarkEVP & Chief Mfg and Supply ChaSELL63$29K

SEC Form 4 filings as of Nov 20, 2026

See cluster-buy signals across all tickers →

What are ISRG's key statistics?

P/E Ratio
54.92
EPS (TTM)
8.27
Beta
1.39
Net Margin
25.54%
ROE
17.00%
Debt / Equity
0.00
52W High
$603.88
52W Low
$328.57

Key statistics as of Nov 7, 2026

How does ISRG's valuation compare with the Healthcare sector?

MetricISRGHealthcare medianCompanies in median
P/E ratio54.928.8145
Net margin25.54%3.62%218
Return on equity17.00%3.50%249

Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Nov 21, 2026). P/E excludes loss-making companies.

What did Intuitive Surgical Inc.'s latest SEC filings say?

Latest 1
8-KMar 2, 2026SEC.gov →

Intuitive Surgical Completes Acquisition of European Distribution Business from ab medica and Affiliates

On March 2, 2026, Intuitive Surgical, Inc. filed an 8-K to announce the formal completion of its acquisition of the da Vinci and Ion distribution business previously operated by ab medica, Abex, Excelencia Robótica, and their respective affiliates. The transaction, which closed on March 1, 2026, marks a strategic shift for the company in its European operations. By acquiring these distribution channels, Intuitive Surgical transitions from a third-party distribution model to a direct-to-market approach for its robotic-assisted surgical systems in the affected regions. The filing serves as a formal notification of this material event under Item 8.01 of Form 8-K. The company provided a press release as an exhibit to the filing, which details the scope of the acquisition. No financial terms of the transaction were disclosed in the filing. The company's Chief Financial Officer, Jamie E. Samath, signed the report on behalf of the registrant.

Material changes
  • ›Completed acquisition of da Vinci and Ion distribution business from ab medica and affiliates.
  • ›Effective date of the acquisition was March 1, 2026.
  • ›Transition to direct distribution model for robotic surgical systems in relevant European markets.

ISRG price chart

Powered by TradingView

What does Intuitive Surgical Inc. do?

Intuitive Surgical, Inc. is a global technology leader in minimally invasive care, specializing in robotic-assisted surgical systems. The company develops and provides advanced da Vinci surgical platforms that enable physicians to perform complex procedures with enhanced precision, control, and visualization, supporting specialties such as urology, gynecology, general surgery, colorectal, thoracic, cardiac, bariatric, head and neck. Its offerings extend to digital solutions, bronchoscopy systems, and data analytics tools that optimize care delivery, improve outcomes, enhance care team and patient experiences, and promote lower costs and broader access. Intuitive Surgical, Inc. collaborates closely with healthcare professionals worldwide to advance less invasive treatments across various procedures. Founded in 1995 and headquartered in Sunnyvale, California, the company plays a pivotal role in transforming surgical practices through innovative technology that prioritizes patient safety, product reliability, and expanded care accessibility.

CEO
Mr. David J. Rosa
Employees
17,021
Market Cap
$162.41B
Ask about ISRGAI research agent